Three companies priced in New York last week–two biotechs and Chinese online real estate marketplace Shenzhen Fangdd Network Technology Co Ltd. (Nasdaq:DUO). The China-USA, free-floating trade anxieties aren’t dissuading the… Read more »
The IPO market for the health sector had a slow week for Veteran’s Day with just three small deals priced, registered and withdrawn. Five more industry-wide deals are getting out… Read more »
In a wild week of health-sector action in the IPO arena, three more Chinese funding seekers eschewed the Shanghai and Hong Kong markets, favoring the more robust Nasdaq the week… Read more »
With signs that public support of Medicare for All is slipping, health-sector IPO action was on fire last week and, in general, there could be eight new IPOs priced this… Read more »
Six healthcare companies shrugged off the stock market chaos and filed for initial public offerings last week, totally $481 million. Who cares about trade wars and Fed policy when, as… Read more »
Schools of all categories will be starting sooner than many think, so time to get that last bit of summer vacation in and forget about real work. Oh, so that’s… Read more »
Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »
The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »
The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where does German biotech stand vis-à-vis the… Read more »
During the second quarter ending June 30, 62 IPOs raised $25.0 billion, the most active quarter by deal count in four years and the most capital raised in five years…. Read more »